Drug Manufacturers - Specialty & Generic · Healthcare
CFO, Board Member
2022-08-04–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Amphastar Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMPH alertsWilliam J. Peters is recorded as Board Member at Amphastar Pharmaceuticals, Inc. (AMPH) since August 4, 2022 and CFO at Amphastar Pharmaceuticals, Inc. (AMPH). The newest filing on record that lists William J. Peters as CFO at Amphastar Pharmaceuticals, Inc. (AMPH) is dated April 15, 2020. Amphastar Pharmaceuticals, Inc. reported in an 8-K filed August 9, 2022 that William J. Peters was appointed Class I director, effective August 4, 2022. The proxy statement of Amphastar Pharmaceuticals, Inc. reports total compensation of $1,957,020 for William J. Peters in fiscal 2019, including a base salary of $528,539. Amphastar Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amphastar Pharmaceuticals, Inc. includes Jack Yongfeng Zhang (CEO and Board Member), William Peters (CFO), Mary Ziping Luo (COO and Board Member) and 7 others.
“approved an increase to the authorized number of directors permitted to serve on the Board from eight (8) to ten (10) directors and appointed each of William J. Peters, the Company's Chief Financial Officer, Executive Vice President of Finance, and Treasurer, and Jacob Liawatidewi, the Company's Executive Vice President of Corporate Administration Center, and Sales and Marketing (together with Mr. Peters, the "New Directors"), to serve as Class I directors, to hold office until the Company's 2023 annual meeting of stockholders and until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation or removal, effective immediately.”
2022-08-04–present
Start not stated–present
Last confirmed April 15, 2020
Drug Manufacturers - Specialty & Generic · Healthcare
CFO, Board Member
2022-08-04–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Amphastar Pharmaceuticals, Inc. (AMPH) | Chief Financial Officer, Senior Vice President of Finance, Treasurer, and President of International Medication Systems, Limited | $528,539 | $1,957,020 |